US Patent 8178555 Apoptosis signal-regulating kinase 1 inhibitors
Patent 8178555 was granted and assigned to Takeda Pharmaceutical Company on May, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8178555 Apoptosis signal-regulating kinase 1 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.